44 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Viking Therapeutics, Inc. (NASDAQ:VKTX) climbed 87.8 percent to $19.51 after announcing top-line results from Phase 2 study of VK2809. The study achieved primary endpoint.
• Bridgford Foods Corporation (NASDAQ:BRID) gained 25.2 percent to $17.15.
• Navidea Biopharmaceuticals Inc (NYSE:NAVB) shares gained 20 percent to $0.2165 after the company reported acceptance into the National Institutes of Health Commercialization Accelerator Program.
• Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares rose 19.2 percent to $3.385. Adial Pharmaceuticals successfully passed the patent opposition period in Europe for AD04 in alcohol use disorder.
• Radcom Ltd. (NASDAQ:RDCM) climbed 17.8 percent to $14.425.
• BioHiTech Global, Inc. (NASDAQ:BHTG) gained 17.1 percent to $3.6292 after the company disclosed that it has received local permit approval to build HEBioT resource recovery facility in Rensselaer New York.
• ChemoCentryx, Inc. (NASDAQ:CCXI) rose 15.4 percent to $12.10. Vifor Pharma Group raised equity stake in ChemoCentryx from 6.6% to 21.2%.
• Tilray, Inc. (NASDAQ:TLRY) climbed 14 percent to $136.979 after the company received US approval to import a medical cannabis study drug for a clinical trial at the UC San Diego.
• Oasmia Pharmaceutical AB (NASDAQ:OASM) gained 14 percent to $2.96.
• Nexeo Solutions Inc (NASDAQ:NXEO) shares rose 13.3 percent to $11.34. Univar Inc (NYSE:UNVR) announced plans to acquire Nexeo in a cash and stock transaction valued at $11.65 per share.
• Surgery Partners, Inc. (NASDAQ:SGRY) climbed 12.2 percent to $16.50.
• Cronos Group Inc. (NASDAQ:CRON) gained 11.3 percent to $11.33.
• Zealand Pharma A/S (NASDAQ:ZEAL) gained 10.5 percent to $18.66 after the company achieved primary and key secondary endpoints in Phase 3 trial with sasiglucagon for severe hypoglycemia.
• Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) climbed 10 percent to $4.575.
• California Resources Corporation (NYSE:CRC) rose 9.6 percent to $40.33.
• Century Aluminum Company (NASDAQ:CENX) gained 9.5 percent to $12.90.
• Akcea Therapeutics, Inc. (NASDAQ:AKCA) climbed 8.8 percent to $27.04. Needham initiated coverage on Akcea Therapeutics with a Buy rating.
• Mersana Therapeutics, Inc. (NASDAQ:MRSN) rose 7.9 percent to $12.02.
• Maiden Holdings, Ltd. (NASDAQ:MHLD) surged 7.6 percent to $2.85.
• Fate Therapeutics, Inc. (NASDAQ:FATE) gained 6.4 percent to $11.78 after the company announced a strategic collaboration with ONO Pharmaceutical to develop off-the-shelf, iPSC-derived CAR-T cell cancer immunotherapies.
• Avon Products, Inc. (NYSE:AVP) rose 6.1 percent to $2.20 following reports Natura and other parties recently approached the company regarding a takeover.
• Nutanix, Inc. (NASDAQ:NTNX) rose 5.8 percent to $49.12 after declining 11.56 percent on Monday.

Check out these big penny stock gainers and losers

Losers

• Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) fell 13.8 percent to $196.85.
• SAExploration Holdings, Inc. (NASDAQ:SAEX) shares dropped 12.8 percent to $7.06.
• Apogee Enterprises, Inc. (NASDAQ:APOG) tumbled 12.7 percent to $42.0919 after the company missed Q2 earnings estimated and cut FY19 guidance.
• China Internet Nationwide Financial Services Inc. (NASDAQ:CIFS) dropped 11.2 percent to $9.9444 after reporting 1H results.
• Blink Charging Co. (NASDAQ:BLNK) shares fell 10.2 percent to $2.38.
• Unity Biotechnology, Inc. (NASDAQ:UBX) shares dipped 10.1 percent to $20.65.
• Tandem Diabetes Care, Inc. (NASDAQ:TNDM) fell 9.9 percent to $36.19.
• Twin Disc, Incorporated (NASDAQ:TWIN) shares dipped 9.8 percent to $23.42 after reporting a $30 million common stock offering.
• Workiva Inc. (NYSE:WK) declined 9.1 percent to $34.42. Morgan Stanley downgraded Workiva from Equal-Weight to Underweight.
• MYnd Analytics, Inc. (NASDAQ:MYND) shares dropped 8.6 percent to $1.92.
• Primerica, Inc. (NYSE:PRI) shares tumbled 8.4 percent to $116.20. Citigroup downgraded Primerica from Neutral to Sell.
• PLx Pharma Inc. (NASDAQ:PLXP) shares fell 8.3 percent to $4.6750.
• Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) dipped 8.2 percent to $5.2725.
• Altimmune, Inc. (NASDAQ:ALT) shares dropped 7.8 percent to $4.51.
• General Mills, Inc. (NYSE:GIS) shares fell 7.6 percent to $44.12. General Mills reported upbeat earnings for its first quarter, while sales missed views.
• athenahealth, Inc. (NASDAQ:ATHN) fell 6.4 percent to $133.9595 after Elliott Management reportedly backed away from its $160 per share bid for the company.
• Hooker Furniture Corporation (NASDAQ:HOFT) fell 6.2 percent to $37.60. Sidoti & Co. downgraded Hooker Furniture from Buy to Neutral.
• Playa Hotels & Resorts N.V. (NASDAQ:PLYA) dipped 5.1 percent to $9.10. Nomura downgraded Playa Hotels & Resorts from Buy to Neutral.
• Presidio Inc (NASDAQ:PSDO) fell 5 percent to $15.57 after announcing a secondary offering of 3 million shares of common stock.
• FedEx Corporation (NYSE:FDX) fell 5 percent to $243.36. FedEx reported weaker-than-expected earnings for its forst quarter, while sales exceeded estimates. The company raised its FY19 earnings outlook and reaffirmed FY19 sales growth of 9 percent.
• argenx SE - ADR (NASDAQ:ARGX) shares fell 4.1 percent to $90.00 after reporting a proposed $300 million offering of American Depositary Shares.
• BorgWarner Inc. (NYSE:BWA) shares fell 3.8 percent to $42.49 after the company lowered its full-year forecast.